Resources

Type of publications
Regions
Diseases

5192 results found

2015 ∙ Ma, ShuJuan Li, Xing Xiong, YiQuan Yao, ALing Chen, Qing

Combination measles-mumps-rubella-varicella vaccine in healthy children: a systematic review and meta-analysis of immunogenicity and safety

  • Newborn
  • Children
  • Mumps
  • Measles
  • Rubella
  • Varicella
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2015 ∙ Wang, S. Y. Cheng, X. H. Li, J. X. Li, X. Y. Zhu, F. C. Liu, P.

Comparing the immunogenicity and safety of 3 Japanese encephalitis vaccines in Asia-Pacific area: A systematic review and meta-analysis

  • Western Pacific
  • South-East Asia
  • Newborn
  • Children
  • Japanese encephalitis
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2015 ∙ Donken, R. de Melker, H. E. Rots, N. Y. Berbers, G. Knol, M. J.

Comparing vaccines: A systematic review of the use of the non-inferiority margin in vaccine trials

  • All age groups
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2015 ∙ Jin, H. Tan, Z. Zhang, X. Wang, B. Zhao, Y. Liu, P.

Comparison of Accelerated and Standard Hepatitis B Vaccination Schedules in High-Risk Healthy Adults: A Meta-Analysis of Randomized Controlled Trials

  • Adolescents
  • Adults
  • Older adults
  • Healthcare workers
  • Hepatitis B
  • Administration
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Low
2015 ∙ Gonzalez-Lorenzo, M. Piatti, A. Coppola, L. Gramegna, M. Demicheli, V. Melegaro, A. Tirani, M. Parmelli, E. Auxilia, F. Moja, L.

Conceptual frameworks and key dimensions to support coverage decisions for vaccines

  • All age groups
  • Acceptance
  • Coverage
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2015 ∙ Fernandez de Casadevante, V. Gil Cuesta, J. Cantarero-Arevalo, L.

Determinants in the Uptake of the Human Papillomavirus Vaccine: A Systematic Review Based on European Studies

  • Europe
  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2015 ∙ Simonella, L., Canfell, K.

Development of a quality framework for models of cervical screening and its application to evaluations of the cost-effectiveness of HPV vaccination in developed countries

  • All age groups
  • Low and Middle Income Countries
  • Human papillomavirus (HPV)
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2015 ∙ Caya, C. A. Boikos, C. Desai, S. Quach, C.

Dosing regimen of the 23-valent pneumococcal vaccination: A systematic review

  • All age groups
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2015 ∙ Mariani, L. Vici, P. Suligoi, B. Checcucci-Lisi, G. Drury, R.

Early direct and indirect impact of quadrivalent HPV (4HPV) vaccine on genital warts: a systematic review

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2015 ∙ Patel, M. Pabst, L. Chattopadhyay, S. Hopkins, D. Groom, H. Myerburg, S. Morgan, J. M.

Economic review of immunization information systems to increase vaccination rates: a community guide systematic review

  • Americas
  • United States of America
  • Children
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
Loading...